# Scenic Biotech: Research, Amsterdam, Netherlands

> Scenic Biotech: Scenic Biotech is a biopharmaceutical company based in Amsterdam, Netherlands, founded in 2017. Based in Amsterdam, Netherlands. Founded 2017.

Source: https://millionrounds.com/startup/scenic-biotech (Millionrounds; every figure on the page links to its filing or article)

Netherlands · [Research startup](https://millionrounds.com/companies)

# Scenic Biotech

Scenic Biotech is a biopharmaceutical company based in Amsterdam, Netherlands, founded in 2017.

Funding reported Last round: Series A

Research Amsterdam, Netherlands

Company summary

- **Founded:** 2017 9 years old
- **Team:** 42 11 to 50 people
- **Funding reported:** 37.6M as listed, currency not stated
- **Last round:** Series A Mar 2022

How sure we are

- ✓ **Listed** We know it exists and what it does
- 2 **Funding reported** A company dataset reports a raise
- 3 **Observed** A filing or a dated announcement confirms a round

No round for Scenic Biotech has been confirmed by a filing or an announcement yet, so nothing here counts toward an investor's record. [How we decide](https://millionrounds.com/methodology)

## About Scenic Biotech

Scenic Biotech is a biopharmaceutical company based in Amsterdam, Netherlands, founded in 2017.

The company focuses on developing disease-modifying therapies for neurological and metabolic diseases, including rare genetic disorders and cancer. Scenic Biotech operates as a spin-out from the Netherlands Cancer Institute and Oxford University and is privately held with a team of around 42 employees. The company utilizes its proprietary discovery platform, Cell-SeqTM, which employs human haploid cells to identify genetic modifiers that can suppress the effects of disease-causing mutations. Scenic Biotech's pipeline includes first-in-class small molecule programs targeting conditions such as lysosomal storage disorders, neurodegeneration, and cancer through immuno-oncology. The company collaborates with major biopharma partners to advance its research and development efforts, aiming to provide innovative therapies for patients with rare genetic disorders and other serious health conditions.

## What company datasets say Scenic Biotech raised

Funding, as reported

Reported in all **37.6M** in the source's currency

Rounds **3**

Last round **Series A**

Last round size **30.8M**

Last round date **Mar 2022**

Investors listed **8**

## Founders and team

From Scenic Biotech's own website: 9 on the team.

- **Oscar Izeboud** CEO & Executive Director
- **Alexander Vos** Chairman of the Board
- **Ben Machielse** Independent Non-executive Director
- **Discovery Sciences** Board of Directors
- **Edward van Wezel** Non-executive Director
- **Michael Wacker** Non-executive Director
- **Stephan Christgau** Non-executive Director
- **Stéphane Verdood** Non-executive Director
- **Thijs Cohen Tervaert** Non-executive Director

## On 3 portfolio pages

Investors who name them

- [Inkef](https://millionrounds.com/fund/inkef-capital)
- [EIR Ventures](https://millionrounds.com/fund/eir-ventures)
- [F INSTITUTE](https://millionrounds.com/fund/f-institute)

Each firm lists Scenic Biotech on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.

## The company, in detail

What they build

Known for

health care rare diseases disease pathways disease protection genes genetic modifier discovery biotechnology research medicine genome pathways metabolic diseases genetic modifiers neurodegenerative diseases genome rebalancing medical research genetic disorders functional genomics genetic research

Built with from their website

WP Engine Microsoft Exchange MySQL Microsoft 365 Apps & Services Wordpress Microsoft Exchange Online Microsoft 365 Outlook PHP Microsoft Email Providers

- **Sector:** Research
- **Industry code:** NAICS 541714, SIC 2834
- **Region:** North Holland
- **Full record:** [Every detail in the company directory](https://millionrounds.com/directory/scenic-biotech)

## Research in Netherlands

Startups like it

- [**Citryll** Oss · founded 2015 *Raised*](https://millionrounds.com/company/citryll)
- [**Leyden Labs** Leiden · founded 2020 *Raised*](https://millionrounds.com/company/leyden-labs)
- [**NorthSea Therapeutics** Amsterdam · founded 2017 *Raised*](https://millionrounds.com/company/northsea-therapeutics)
- [**Synerkine Pharma** Leiden · founded 2018 *Raised*](https://millionrounds.com/company/synerkine-pharma)
- [**ENPICOM** 's-Hertogenbosch · founded 2015 *Raised*](https://millionrounds.com/company/enpicom)
- [**PHOSPHOENIX** Amsterdam · founded 2019 *Raised*](https://millionrounds.com/company/phosphoenix)
- [**AZAFAROS B.V.** Naarden · founded 2018](https://millionrounds.com/startup/azafaros-b-v)
- [**VectorY** Amsterdam · founded 2020](https://millionrounds.com/startup/vectory)

## Is this your company?

Add your raise, your deck and your story, and put Scenic Biotech in front of investors. Or tell us what we have wrong.

[List your startup](https://millionrounds.com/list-your-startup)[Send a correction](https://millionrounds.com/corrections)